Skip to main content
. Author manuscript; available in PMC: 2024 May 1.
Published in final edited form as: Gynecol Oncol. 2023 Mar 21;172:54–64. doi: 10.1016/j.ygyno.2023.03.010

Figure 6.

Figure 6.

Correlation of chromatin remodeling gene (CRG) alterations in endometrial carcinomas with histopathologic features. (A) Bar-plot showing the distribution of myometrial invasion among CRG-altered and CRG-wild-type uterine endometrioid carcinomas. (B) Bar-plot showing the distribution of lymphovascular invasion among CRG-altered and CRG-wild-type uterine endometrioid carcinomas. (C) Box and whisker plots comparing the depth of myometrial invasion between CRG-altered and CRG-wild-type endometrial carcinomas among the four molecular subtypes of endometrial carcinoma.

UEC, Uterine endometrioid carcinoma; POLE, POLE exonuclease domain mutated carcinoma; MSI-H, DNA mismatch repair deficient carcinoma; CN-L, TP53 wild-type non-hypermutant endometrial carcinomas; CN-H, TP53 altered non-hypermutant endometrial carcinomas.